PL405743A1 - Nowe zastosowanie N-[2-[4-(4-metoksyfenylo)-1,3-tiazol-2-ilo]etylo]-2-okso-1,5,6,7-tetrahydrocyklopenta[b] pirydyno-3-karboksyamidu - Google Patents

Nowe zastosowanie N-[2-[4-(4-metoksyfenylo)-1,3-tiazol-2-ilo]etylo]-2-okso-1,5,6,7-tetrahydrocyklopenta[b] pirydyno-3-karboksyamidu

Info

Publication number
PL405743A1
PL405743A1 PL40574313A PL40574313A PL405743A1 PL 405743 A1 PL405743 A1 PL 405743A1 PL 40574313 A PL40574313 A PL 40574313A PL 40574313 A PL40574313 A PL 40574313A PL 405743 A1 PL405743 A1 PL 405743A1
Authority
PL
Poland
Prior art keywords
tetrahydrocyclopenta
thiazol
methoxyphenyl
oxo
ethyl
Prior art date
Application number
PL40574313A
Other languages
English (en)
Other versions
PL226024B1 (pl
Inventor
Wiesław Świętnicki
Original Assignee
Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością filed Critical Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL405743A priority Critical patent/PL226024B1/pl
Priority to PCT/PL2014/050067 priority patent/WO2015060738A1/en
Publication of PL405743A1 publication Critical patent/PL405743A1/pl
Publication of PL226024B1 publication Critical patent/PL226024B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem wynalazku jest N-[2-[4-(4-metoksyfenylo)-1,3-tiazol-2-ilo] etylo]-2-okso-1, 5,6,7-tetrahydrocyklopenta [b] pirydyno-3-karboksyamidu o wzorze 1 do zastosowania jako środek przeciwnowotworowy albo inhibitor pomp efluksowych.
PL405743A 2013-10-23 2013-10-23 Zastosowanie N-[2-[4-(4-metoksyfenylo)-1,3-tiazol-2-ilo]etylo]- -2-okso-2,5,6,7-tetrahydrocyklopenta[b] pirydyno-3-karboksyamidu PL226024B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL405743A PL226024B1 (pl) 2013-10-23 2013-10-23 Zastosowanie N-[2-[4-(4-metoksyfenylo)-1,3-tiazol-2-ilo]etylo]- -2-okso-2,5,6,7-tetrahydrocyklopenta[b] pirydyno-3-karboksyamidu
PCT/PL2014/050067 WO2015060738A1 (en) 2013-10-23 2014-10-23 N-{2- [4- (4-methoxyophenyl)-1,3-thiazol-2-yl] ethyl}-2-oxo-2, 5, 6, 7-tetrahydro-1h-cyclopenta [b] pyridine-3-carboxamide for use in the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL405743A PL226024B1 (pl) 2013-10-23 2013-10-23 Zastosowanie N-[2-[4-(4-metoksyfenylo)-1,3-tiazol-2-ilo]etylo]- -2-okso-2,5,6,7-tetrahydrocyklopenta[b] pirydyno-3-karboksyamidu

Publications (2)

Publication Number Publication Date
PL405743A1 true PL405743A1 (pl) 2015-04-27
PL226024B1 PL226024B1 (pl) 2017-06-30

Family

ID=52004034

Family Applications (1)

Application Number Title Priority Date Filing Date
PL405743A PL226024B1 (pl) 2013-10-23 2013-10-23 Zastosowanie N-[2-[4-(4-metoksyfenylo)-1,3-tiazol-2-ilo]etylo]- -2-okso-2,5,6,7-tetrahydrocyklopenta[b] pirydyno-3-karboksyamidu

Country Status (2)

Country Link
PL (1) PL226024B1 (pl)
WO (1) WO2015060738A1 (pl)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2002861A3 (cs) 1999-09-10 2002-06-12 Merck & Co., Inc. Inhibitory tyrosinkinázy
WO2002076439A2 (en) * 2001-03-23 2002-10-03 The Board Of Trustees Of The University Of Illinois Compounds capable of modulating the activity of multidrug transporters and therapeutic use of the same
AU2011205283B2 (en) * 2010-01-13 2014-07-10 Tempero Pharmaceuticals, Inc. Compounds and methods
IT1401390B1 (it) 2010-08-06 2013-07-18 Silca Spa Metodo di verifica dell'integrita' degli utensili in macchine automatiche multiutensili duplicatrici di chiavi e macchina che attua il metodo

Also Published As

Publication number Publication date
WO2015060738A1 (en) 2015-04-30
PL226024B1 (pl) 2017-06-30

Similar Documents

Publication Publication Date Title
CY1120703T1 (el) Ετεροκυκλικες ενωσεις και χρησεις αυτων
CY1120635T1 (el) Βενζαμιδια αμινοετεροαρυλιου ως αναστολεις κινασης
MX374439B (es) Compuesto de piridona como inhibidor de c-met
DK3684767T3 (da) Heterocykliske forbindelser som pad-inhibitorer
EP2984134A4 (en) CHOLINIZED NETWORKING COMPOSITION FOR FRACTURING LIQUIDS
CN106536480A8 (zh) 吡咯烷‑2,5‑二酮衍生物、药物组合物及用作ido1抑制剂的方法
EA201690473A1 (ru) Комбинированный состав двух противовирусных соединений
BR112017009648A2 (pt) composto, métodos para tratamento de doenças alérgicas ou outras condições inflamatórias ou prevenção de doença, de rinite alérgica ou asma, composição, e, uso de um composto.
BR112014017021A8 (pt) inibidores de irak e usos dos mesmos
MX381487B (es) Ciertos inhibidores de la proteina quinasa.
UA118259C2 (uk) Гетероциклічні аміди як інгібітори кінази
SI3240538T1 (sl) Uporaba masitiniba za zdravljenje subpopulacije bolnikov z amiotrofično lateralno sklerozo
EA201690523A1 (ru) Триазолопиридины, композиции и способы их применения
EP3535252A4 (en) COMPOSITION WITH A COMBINATION OF EPICATECHIN AN ANTI-VICORINE COMPOUND
MX2018006802A (es) Derivados de fenilo como agonistas del receptor de canabinoides 2.
CR20150417A (es) Compuestos de azetidiniloxifenilpirrolidina
MX2016015856A (es) Derivados de naftiridinadiona.
EA201791099A1 (ru) Хинолин карбоксамиды для применения в лечении лейкоза
LT3615027T (lt) Tripakeistųjų benzotriazolo darinių kaip dihidroorotato oksigenazės inhibitorių naudojimo būdai
DK3790873T3 (da) 1h-indazol-3-carboxamidforbindelser som glycogensynthase-kinase-3-beta-inhibitorer
MX377963B (es) Composición acuosa.
PL405743A1 (pl) Nowe zastosowanie N-[2-[4-(4-metoksyfenylo)-1,3-tiazol-2-ilo]etylo]-2-okso-1,5,6,7-tetrahydrocyklopenta[b] pirydyno-3-karboksyamidu
EA201690749A1 (ru) Новые ингибиторы sglt1
DK3331873T3 (da) 4-(3-pyrazolylamino)-benzimidazolderivat som jak1-inhibitor til behandling af kræft
JO3298B1 (ar) مشتقات جليكوبيرانوسيل-مستبدل و اندول-يوريا و استعمالاتهم كمثبطات sglt